Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-10-28 to 2024-10-29
Current total value of award: $1631.03
Description: 4566242042!QUILLIVANT XR 25 MG/5 ML SUSP 120ML